Eyevensys
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Biopark Bat B 11, Paris, Ile-de-France, ...Phone Number
+33 184791060Website
www.eyevensys.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Eyevensys
Eyevensys is a privately held, clinical-stage biotechnology company developing its innovative technology to enable the sustained intraocular production of therapeutic proteins to treat a broad range of ophthalmic diseases. The company was established in 2008 and is headquartered out of Paris, France.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Eyevensys your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Eyevensys launches new products
Check out if Eyevensys is spiking on competitors!
Eyevensys, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Eyevensys has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Eyevensys
Click to see if Eyevensys had a recent Job posting/layoffs
Earning: See what the market has to say on Eyevensys recently announced quarterly report
Funding: Get notified immidiatlly once Eyevensys has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Eyevensys as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Eyevensys is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Eyevensys is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Eyevensys.
Eyevensys financials insights
Gather financial insights about Eyevensys, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$1.7M
2020
Series B
$30M
2021
Series B
$12M
Eyevensys Tech Stack
A closer look at the technologies used by Eyevensys
Most Recent Scoops
Left Company
Executive Move
Board of Directors
Funding
Funding
Funding
Funding
Eyevensys News & Media
Eyevensys Recaps Highlights from Investigator Meeting and Presentations at the ARVO 2022 Annual Conference
PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eyevensys Recaps Highlights from Investigator Meeting and Presentations at the ARVO 2022 Annual ConferenceEyevensys Enters Collaboration with Phillips-Medisize and Minnetronix Medical
PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #Finance--Eyevensys has entered into strategic engagements with US-based medical device manufacturers Phillips-Medisize and Minnetronix Medical.Eyevensys lève 12 millions de dollars dans un tour de table série B Plus
PARIS et CAMBRIDGE, Massachusetts--(BUSINESS WIRE)--Eyevensys, une société privée de biotechnologie au stade clinique qui développe des thérapies géniques non virales pour les maladies oculaires, annonce aujourd'hui qu'elle a levé 12 millions de dollars dans un tour de table série B Plus dirigé par Korea Investment Partners ; les investisseurs existants participeront également au tour de table. Ce financement permettra à Eyevensys d'accélérer le développement de son programme EYS809 pour le traEyevensys Raises $12M in a Series B Plus Funding Round
PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #Eyevensys--Eyevensys, a private biotech developing gene therapies for ophthalmic diseases, today announces it has raised $12M in a Series B Plus funding round.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eyevensys
Sign Up For FreeTo access detailed company insights
Eyevensys is a privately held, clinical-stage biotechnology company developing its innovative technology to enable the sustained intraocular production of therapeutic proteins to treat a broad range of ophthalmic diseases. The company was established in 2008 and is headquartered out of Paris, France.... Read More
